Adaptive Biotechnologies (ADPT) EBT Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) EBT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 12.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 64.58% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 15.14% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 56.92% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.81% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -27.03% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -15.03% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 16.39% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 7.29% |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | -77.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.12% |
| Dec 31, 2025 | 53.42% |
| Sep 30, 2025 | 129.74% |
| Jun 30, 2025 | -166.51% |
| Mar 31, 2025 | 37.97% |
| Dec 31, 2024 | 55.37% |
| Sep 30, 2024 | 36.22% |
| Jun 30, 2024 | 3.27% |
| Mar 31, 2024 | 16.40% |
| Dec 31, 2023 | -78.65% |
| Sep 30, 2023 | -3.02% |
| Jun 30, 2023 | 27.76% |
| Mar 31, 2023 | 72.35% |
| Dec 31, 2022 | 39.30% |
| Sep 30, 2022 | 82.18% |
| Jun 30, 2022 | 81.10% |
| Mar 31, 2022 | 41.98% |
| Dec 31, 2021 | -42.81% |
| Sep 30, 2021 | 55.05% |
| Jun 30, 2021 | 46.07% |